SREBF2 and hepatocellular carcinoma: Furthermore, research has demonstrated that PF-429242 suppresses the expression of SREBP2 target genes and cholesterol synthesis in hepatoma HepG2 cells, exhibiting an IC50 of 0.5 μM.